There are novel agents in the pipeline for diabetes
Kathy Hitchens, PharmD, Msba · Drug Topics Supplements · 2005
In the next few years, the treatment of diabetes may change dramatically. If just some of the drugs in phase III trials fulfill their current promise and reach market, we may see the following developments: